Document is current
Any future updates will be listed below
-
Authors
Wang, Zhinong
Chen, Xiaoning
Tang, Liuqing
Wu, Xiaokai
Huang, Aiyu
Zhang, Hao
- License Information
-
More Information
Article History
Received: 30 January 2026
Accepted: 24 May 2026
First Online: 6 June 2026
Declarations
:
: Model training and evaluation were performed using 39,156 de-identified WES/WES Trio cases obtained from multiple clinical centers in China. Written informed consent was obtained from all participants or their legal guardians. Only de-identified data were used for this study. All procedures were conducted in accordance with relevant institutional and ethical requirements.
: Not applicable.
: Hao Zhang is the founder and an executive of Xbiolabs, Inc. Zhinong Wang, Xiaoning Chen, and Liuqing Tang are employees of Xbiolabs, Inc. Xiaokai Wu and Aiyu Huang are employees of Beijing Wenyin Biotechnology Co., Ltd. The authors declare that there are no other competing financial or non-financial interests.
